Skip to main content
Log in

Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease

  • Pediatric Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective

Assessment of electrocardiographic (ECG) effects of dexmedetomidine.

Design

Prospective observational study including children 0–17 years of age with congenital heart disease (CHD) and children following cardiothoracic surgery. Patients who did not receive dexmedetomidine were used as a control group. All patients had two ECGs: one baseline, pre-dexmedetomidine (T1) and one during dexmedetomidine infusion (T2).

Measurements and results

Fifty-one patients, median age of 0.5 years (IQR = 3.4), and 25 patients, age 0.25 (IQR = 2.9), were included in the dexmedetomidine and control groups, respectively. Forty received a dexmedetomidine-loading dose of 1 µg/kg (IQR = 0.5). At T2, the dexmedetomidine infusion was 1 µg/kg/h (IQR = 0.5). In the dexmedetomidine group, heart rate (HR) decreased from 140 ± 22 to 115 ± 23 (P < 0.001); PR, PRc and PR index changed from 115 ± 28 to 122 ± 29 ms (P = 0.01), 174 ± 38 to 167 ± 35 ms (P = 0.07) and 15,882 ± 3,565 to 13,792 ± 3,311 (P < 0.001), respectively. QRS decreased from 84 ± 21 to 80 ± 21 ms (P = 0.02), and QTc had no change (433 ± 47 to 435 ± 36 ms). When compared to the control group, none of the ECG intervals had any difference other than a trend towards lower HR (P = 0.08). Neonates and infants had a bigger drop in the HR compared to older children (P < 0.001), while other parameters were similar. At T2 none of the dexmedetomidine group patients had atrioventricular block or other arrhythmia. Four patients in the control group had accelerated junctional rhythm.

Conclusions

Use of dexmedetomidine in patients with CHD and patients following cardiothoracic surgery is not associated with any significant ECG interval abnormalities other than a trend towards lower HR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Triltsch AE, Welte M, von Homeyer P, Grosse J, Genähr A, Moshirzadeh M, Sidiropoulos A, Konertz W, Kox WJ, Spies CD (2002) Bispectral index-guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo-controlled phase II study. Crit Care Med 30:1007–1014

    Article  CAS  PubMed  Google Scholar 

  2. Venn RM, Bradshaw CJ, Spencer R, Brealey D, Caudwell E, Naughton C, Vedio A, Singer M, Feneck R, Treacher D, Willatts SM, Grounds RM (1999) Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 54:1136–1142

    Article  CAS  PubMed  Google Scholar 

  3. Mukhtar AM, Obayah EM, Hassona AM (2006) The use of dexmedetomidine in pediatric cardiac surgery. Anesth Analg 103:52–56

    Article  CAS  PubMed  Google Scholar 

  4. Chrysostomou C, Di Filippo S, Manrique AM, Schmitt CG, Orr RA, Casta A, Suchoza E, Janosky J, Davis PJ, Munoz R (2006) Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med 7:126–131

    Article  PubMed  Google Scholar 

  5. Chrysostomou C, Sanchez De Toledo J, Avolio T, Motoa MV, Berry D, Morell VO, Orr R, Munoz R (2009) Dexmedetomidine use in a pediatric cardiac intensive care unit: Can we use it in infants after cardiac surgery? Pediatr Crit Care Med [Epub ahead of print]

  6. Tobias JD, Berkenbosch JW (2004) Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J 97:451–455

    Article  PubMed  Google Scholar 

  7. Munro HM, Tirotta CF, Felix DE, Lagueruela RG, Madril DR, Zahn EM, Nykanen DG (2007) Initial experience with dexmedetomidine for diagnostic and interventional cardiac catheterization in children. Paediatr Anaesth 17:109–112

    Article  PubMed  Google Scholar 

  8. Barton KP, Munoz R, Morell VO, Chrysostomou C (2008) Dexmedetomidine as the primary sedative during invasive procedures in infants and toddlers with congenital heart disease. Pediatr Crit Care Med 9:612–615

    Article  PubMed  Google Scholar 

  9. Chrysostomou C, Beerman L, Shiderly D, Berry D, Morell VO, Munoz R (2008) Dexmedetomidine: a novel drug for the treatment of atrial, junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study. Anesth Analg 107:1514–1522

    Article  CAS  PubMed  Google Scholar 

  10. Tobias JD (2006) Dexmedetomidine to treat opioid withdrawal in infants following prolonged sedation in the pediatric ICU. J Opioid Manag 2:201–205

    PubMed  Google Scholar 

  11. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD (2000) The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 93:382–394

    Article  CAS  PubMed  Google Scholar 

  12. Bloor BC, Ward DS, Belleville JP, Maze M (1992) Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 77:1134–1142

    Article  CAS  PubMed  Google Scholar 

  13. Hammer GB, Drover DR, Cao H, Jackson E, Williams GD, Ramamoorthy C, Van Hare GF, Niksch A, Dubin AM (2008) The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth Analg 106:79–83

    Article  CAS  PubMed  Google Scholar 

  14. Mirvis DM, Goldberger AL (2005) Electrocardiography. In: Zipes DP, Libby P, Bonow RO, Braunwald E (eds) Braunwald’s heart disease: a textbook of cardiovascular medicine. Elsevier Saunders, Philadelphia, p 118

  15. Cagli K, Ozbakir C, Ergun K, Bakuy V, Circi R, Circi P (2006) Electrocardiographic changes after coronary artery surgery. Asian Cardiovasc Thorac Ann 14:294–299

    PubMed  Google Scholar 

  16. Chrysostomou C, Schmitt CG (2008) Dexmedetomidine: sedation, analgesia and beyond. Expert Opin Drug Metab Toxicol 4:619–627

    Article  CAS  PubMed  Google Scholar 

  17. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW, Rocha MG (2009) Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 301:489–499

    Article  CAS  PubMed  Google Scholar 

  18. Snapir A, Posti J, Kentala E, Koskenvuo J, Sundell J, Tuunanen H, Hakala K, Scheinin H, Knuuti J, Scheinin M (2006) Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects. Anesthesiology 105:902–910

    Article  CAS  PubMed  Google Scholar 

  19. Atterhög JH, Loogna E (1977) P–R interval in relation to heart rate during exercise and the influence of posture and autonomic tone. J Electrocardiol 10:331–336

    Article  PubMed  Google Scholar 

  20. Alimurung MM, Massell BF (1956) The normal P–R interval in infants and children. Circulation 13:257–262

    CAS  PubMed  Google Scholar 

  21. Danter WR, Carruthers SG (1990) The heart rate-PR interval relationship: a model for evaluating drug actions on SA and AV nodal function. Br J Clin Pharmacol 30:490–492

    CAS  PubMed  Google Scholar 

  22. Berkenbosch JW, Tobias JD (2003) Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin. Pediatr Crit Care Med 4:203–205

    Article  PubMed  Google Scholar 

  23. Shah AN, Koneru J, Nicoara A, Goldfeder LB, Thomas K, Ehlert FA (2007) Dexmedetomidine related cardiac arrest in a patient with permanent pacemaker; a cautionary tale. Pacing Clin Electrophysiol 30:1158–1160

    Article  PubMed  Google Scholar 

  24. Sichrovsky TC, Mittal S, Steinberg JS (2008) Dexmedetomidine sedation leading to refractory cardiogenic shock. Anesth Analg 106:1784–1786

    Article  CAS  PubMed  Google Scholar 

  25. Herndon RF, Meroney WH, Pearson CM (1955) The electrocardiographic effects of alterations in concentration of plasma chemicals. Am Heart J 50:188–202

    Article  CAS  PubMed  Google Scholar 

  26. Weiner M, Epstein FH (1970) Signs and symptoms of electrolyte disorders. Yale J Biol Med 43:76–109

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Support for this work was provided by the Department of Pediatric Cardiology at Children’s Hospital of Pittsburgh and by Hospira Inc., Lake Forest, Illinois.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Constantinos Chrysostomou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chrysostomou, C., Komarlu, R., Lichtenstein, S. et al. Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease. Intensive Care Med 36, 836–842 (2010). https://doi.org/10.1007/s00134-010-1782-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-010-1782-z

Keywords

Navigation